• Minimally drug-absorbing chip materials for accurate compound testing 
• Better approximation of the in vivo microenvironment through increased shear stress in the vascular channel 

• A preactivated tissue culture membrane to simplify the user workflow 

• Reduced imaging distance, expanding compatibility for microscopy
• Application: Customers who interested in non-stretch organ models (Liver, Brain, Kidney) for applications using drugs that are prone to material absorption

FDA's ISTAND* Pilot Program accepts a submission of first organ-on-a-chip technology designed to predict human drug-induced liver injury (DILI)

* Innovative Science and Technology Approaches for New Drugs (ISTAND)

Developing an RNA Signature for Radiation Injury Using a Human Liver-on-a-Chip Model. Radiation research, 10.1667/RADE-24-00047.1. 2 Aug. 2024

Enzymatic Modulation of the Pulmonary Glycocalyx Enhances Susceptibility to Streptococcus pneumoniae. American journal of respiratory cell and molecular biology, 2024